EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation

Byounghwi Ko, Younhee Park, Sung Min Kim, Young Jin Kim, Hee Byung Koh, Hyung Woo Kim, Honglin Piao, Virithy Lon, Minsun Jung, Hyun Jeong Kim, Juhan Lee, Kyu Ha Huh, Beom Seok Kim, Myoung Soo Kim, Jin Sug Kim, Seungyeup Han, Young Joo Kwon, Jaeseok Yang

American Journal of Nephrology · 2026-11-06

DOI: 10.1159/ajn/ablag034 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction Antibody-mediated rejection (ABMR) remains a leading cause of late kidney allograft loss. Recently, microvascular inflammation in kidney biopsy without detectable donor-specific antibodies (DSA)—termed DSA-negative ABMR (DSAneg ABMR)—is increasingly recognized. Methods We used the nationwide Korean Transplantation Registry (KOTRY) to compare outcomes among biopsy-proven DSA-positive ABMR (DSApos ABMR), DSAneg ABMR, and T-cell–mediated rejection (TCMR). From 10,391 kidney transplant recipients, 740 patients met inclusion criteria (DSAneg ABMR 90; DSApos ABMR 124; TCMR 526). The primary outcome was kidney graft failure. Cause-specific competing risk models were applied. To elucidate mechanisms of DSAneg ABMR, we integrated KOTRY with an in-depth single-center data, enrolling 56 patients for serologic, genetic, and pathologic investigations using stored biospecimens. Results Over 2,610.1 person-years (median follow-up 3.10 years), the primary outcome occurred in 93 (12.6%) patients (14 in DSAneg ABMR, 15 in DSApos ABMR, and 64 in TCMR; incidence 3.56/100 person-years). Versus DSAneg ABMR, fully adjusted hazard ratios (HRs) for the kidney graft failure were 0.78 (95% CI, 0.36–1.69; P=0.52) for DSApos ABMR and 0.64 (0.35–1.18; P=0.15) for TCMR. In the etiologic cohort (n=56), frequent findings included MIC-A and MIC-B gene mismatches (16/19 [84.2%] and 15/19 [78.9%]), SIRPα B-to-A incompatibility (7/19 [36.8%]), kidney-relevant autoantibodies (21/52 [40.4%]), and missing self for NK cells (9/18 [50.0%]). Late-appearing DSAs, MIC-A mismatch, and missing self were associated with worse graft outcomes. While overall Banff scores were comparable between the ABMR groups, the DSAneg group exhibited higher tubulitis and lower microvascular inflammation scores. Conclusion Both DSApos ABMR and DSAneg ABMR confer higher risks of adverse outcomes than TCMR in a Korean national cohort. DSAneg ABMR is etiologically heterogeneous with different prognosis. Further prospective studies with systematic biospecimen collection are warranted.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →